BIOS Capital Management, LP
Top Portfolio Positions
6 positions ·
$52,866,301 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ACTU |
Actuate Therapeutics, Inc.
Healthcare
|
10,049,996 | $27,536,988 | 52.09% | |
| IRD |
Opus Genetics, Inc.
Healthcare
|
3,683,429 | $16,759,601 | 31.70% | |
| CGTX |
Cognition Therapeutics Inc
Healthcare
|
6,000,000 | $4,559,999 | 8.63% | |
| RNTX |
Rein Therapeutics, Inc.
Healthcare
|
1,982,375 | $2,577,087 | 4.87% | |
| LTRN |
Lantern Pharma Inc.
Healthcare
|
864,435 | $1,184,275 | 2.24% | |
| INAB |
In8bio, Inc.
Healthcare
|
167,805 | $248,351 | 0.47% |
Portfolio Trend
6 quarters · across all stocks
Holdings in CGTX
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,559,999 | 6,000,000 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $8,099,999 | 6,000,000 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $8,099,999 | 6,000,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,859,999 | 6,000,000 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,525,999 | 6,000,000 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,205,999 | 6,000,000 | Shares | Defined | 2025-02-18 | |
| No 13F history on record for this holder in this stock. | ||||||